193
Views
24
CrossRef citations to date
0
Altmetric
SHORT REPORT

No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS

&
Pages 328-330 | Received 09 Dec 2009, Accepted 28 Jan 2010, Published online: 03 May 2010

References

  • Garbuzova-Davis S, Sanberg PR. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp Neurol. 2009;216:3–6.
  • Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, . Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm. 2007;114: 1395–406.
  • Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on SOD mice (amyotrophic lateral sclerosis). Life Sci. 2000;67:53–9.
  • Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, . Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res. 2003;12:255–70.
  • Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, . Human neural stem cell grafts ameliorate motor neuron disease in SOD1 transgenic rats. Transplantation. 2006;82: 865–75.
  • Ibrahim A, Li Y, Li D, Raisman G, El Masry WS. Olfactory ensheathing cells: ripples of an incoming tide? Lancet Neurol. 2006;5:453–7.
  • Watts J. Controversy in China. Lancet. 2005;365:109–10.
  • Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, . Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005; 128:2951–60.
  • Martin LJ, Liu Z. Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. J Neuropathol Exp Neurol. 2007;66:1002–18.
  • Morita E, Watanabe Y, Ishimoto M, Nakano T, Kitayama M, Yasui K, . A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol. 2008;213: 431–8.
  • Chen L, Huang H, Zhang J, Zhang F, Liu Y, Xi H, . Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Zhongguo XiuFu ChongJianWai KeZa Zhi. 2007;21:961–6.
  • Huang H, Chen L, Xi H, Wang H, Zhang J, Zhang F, . Foetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant. 2008;22:710–8.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, . Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci. 2008;265:78–83.
  • Chew S, Khandji AG, Montes J, Mitsumoto H, Gordon PH. Olfactory ensheathing glia injections in Beijing: misleading patients with ALS. Amyotroph Lateral Scler. 2007;8:314–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.